Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: Comparison of six antihypertensive agents

Circulation

Volumn 95, Issue 8, 1997, Pages 2007-2014

  Gottdiener, John S ^a   Reda, Domenic J ^b   Massie, Barry M ^b   Materson, Barry J ^b   Williams, David W ^b   Anderson, Robert J ^b  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

diuretics; drugs; echocardiography; hypertension; hypertrophy; trials

Indexed keywords

ATENOLOL; CAPTOPRIL; CLONIDINE; DILTIAZEM; HYDROCHLOROTHIAZIDE; PRAZOSIN;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030895133     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.8.2007     Document Type: Article

References (31)

1. Casale PN, Devereux RB, Milner M. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med. 1986;105:173-178.
2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322: 1561-1566.
3. Koren MJ, Devereux RB, Casale PN. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114:345-352.
4. Levy D, Salomon M, D'Agostino R, Belanger A, Kannel W. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation. 1994;90:1786-1793.
5. Yuranev AP, Dyakonova HG, Novikov ID, Vitols A, Pahl L, Haynemann G, Wallrabe D, Tsifkova R, Romanovska L, Niderle P, Tsiskarishvili D, Davarashvili T, Gelovani K, Kochachidze T, Balash A. Management of essential hypertension in patients with different degrees of left ventricular hypertrophy: multicenter trial. Am J Hypertens. 1992;5:182S-189S.
6. Liebson PR. Clinical studies of drug reversal of hypertensive left ventricular hypertrophy. Am J Hypertens. 1990;3:512-517.
7. Schulman S, Weiss J, Becker L, Gottlieb S, Woodruff K, Weisfeldt M, Gerstenblith G. The effects of antihypertensive therapy on left ventricular mass in elderly patients. N Engl J Med. 1990;322:1350-1356.
8. Dahlof B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients: a metaanalysis of 109 treatment studies. Am J Hypertens. 1992;5:95-110.
9. Tarazi RC, Sen S, Fouad FM, Wicker P. Regression of myocardial hypertrophy: conditions and sequelae of reversal in hypertensive heart disease. In: Alpert NR, ed. Perspectives in Cardiovascular Research. Vol 7, Myocardial Hypertrophy and Failure. New York, NY: Raven Press; 1983:637-652.
10. Liebson P. Echocardiographic assessment of the left ventricle in hypertension: perspectives on epidemiologic studies and clinical trials. J Vasc Biol Med. 1993;4:285-310.
11. Gottdiener JS, Reda DJ, Materson BJ, Massie BM, Notargiacomo A, Hamburger RJ, Williams DW, Henderson WG. Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. J Am Coll Cardiol. 1994;24:1492-1498.
12. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, Hamburger RJ, Fye C, Lakshman R, Gottdiener J. Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo: the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med. 1993;328: 914-921.
13. Sahn DJ, DeMaria A, Kisslo J, Weyman A, the Committee on M-mode Standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-1083.
14. Troy BL, Pombo J, Rackley CE. Measurement of left ventricular wall thickness and mass by echocardiography. Circulation. 1972;45:602-611.
15. Devereux RB, Lutas EM, Casale RN, Kligfield P, Eisenberg RR, Hammond IW, Miller DW, Reis G, Alderman MH, Laragh JH. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol. 1984;4:1222-1230.
16. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP. Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol. 1987;59:956-960.
17. Diggle P, Liang K, Zeger S. Analysis of Longitudinal Data. Oxford, UK: Clarendon Press; 1994.
18. Little RJA. Modeling the drop-out mechanism in repeated-measures studies. J Am Stat Assoc. 1995;90:1112-1121.
19. SAS Institute Inc. SAS/STAT Users Guide, Version 6. 4th ed. Cary, NC: SAS Institute; 1989.
20. Massie BM. Effect of diuretic therapy on hypertensive left ventricular hypertrophy. Eur Heart J. 1992;13(suppl G):53-60.
21. Pfeffer MA, Pfeffer JM. Reversing cardiac hypertrophy in hypertension. N Engl J Med. 1987;322:1388-1390.
22. Giles TD, Sander GE, Roffidal LC, Thomas MG, Given MB, Quiroz AC. Comparison of nitrendipine and hydrochlorothiazide for systemic hypertension. Am J Cardiol. 1987;60:103-106.
23. Pfeffer MA, Pfeffer JM. Pharmacologic regression of cardiac hypertrophy in experimental hypertension. J Cardiovasc Pharmacol. 1984;6(suppl 6):S865-S869.
24. Pegram BL, Ishise S, Frohlich ED. Effects of methyldopa, clonidine and hydralazine on cardiac mass and haemodynamics in Wistar Kyoto and spontaneously hypertensive rats. Cardiovasc Res. 1982; 16:40-46.
25. Devereux RB, Pennert K, Cody RJ. Relation of renin-angiotensin system activity to left ventricular hypertrophy and function in experimental and human hypertension. J Clin Hypertens. 1987;3:87-103.
26. Burnier M, Brunner HR. Neurohormonal consequences of diuretics in different cardiovascular syndromes. Eur Heart J. 1992;13(suppl G): 28-33.
27. Moser M, Setaro JF. Antihypertensive drug therapy and regression of left ventricular hypertrophy: a review with a focus on diuretics. Eur Heart J. 1991;12:1034-1039.
28. Liebson PR, Grandits GA, Dianzumba S, Prineas RJ, Grimm RH Jr, Neaton JD, Stamler J. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation. 1995;91:698-706.
29. Neaton JD, Grimm RJ Jr, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, Cutler JA, Flack JM, Schoenberger JA, McDonald R, Lewis CE, Liebson PR, Treatment of Mild Hypertension Study Research Group. Treatment of Mild Hypertension Study: final results. JAMA. 1993;270:713-724.
30. Frohlich ED. The heart in hypertension: a 1991 overview. Hypertension. 1991;18(suppl 5):62-68.
31. Siscovick DS, Raghunathan TE, Psaty BM, Koepsell TD, Wicklund KG, Lin X, Cobb L, Rautaharju PM, Copass MK, Wagner EH. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med. 1993;330:1852-1857.